Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals ... which is not clinically significant because pulse oximeters only measure in whole numbers. 10 Further analysis showed ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

The company gained FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over ... The declining top and bottom-line performances during the fourth quarter, led ...

Another vital part of the kit is a pulse oximeter, which [Aris] uses to make sure he’s getting enough oxygen. His O 2 saturation actually goes up from his baseline when the hood is on and ...

Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles ...

Apple stock also rose 0.8% to 168.22. MASI Stock: Potential Sales Boost Masimo makes pulse oximeters used in hospitals. These devices are based on its "signal extraction technology," or SET.

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than ...

even though their frequent movement and poor perfusion stymied traditional pulse oximetry. SET ® overcame those seemingly insurmountable obstacles, and Masimo’s continued innovation is driving ...